- Reuters•5 hours ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
AstraZeneca (AZN) provided an update on its late-stage immuno-oncology program for first-line NSCLC.
- Investor's Business Daily•2 days ago
The FDA's track record for oncology "hits" bodes well for Merck's Keytruda plus chemo combo, Leerink says.
AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||28.08 - 28.31|
|52 Week Range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.10|
|Dividend & Yield||0.90 (3.16%)|
|1y Target Est||N/A|